NL7406748A - - Google Patents

Info

Publication number
NL7406748A
NL7406748A NL7406748A NL7406748A NL7406748A NL 7406748 A NL7406748 A NL 7406748A NL 7406748 A NL7406748 A NL 7406748A NL 7406748 A NL7406748 A NL 7406748A NL 7406748 A NL7406748 A NL 7406748A
Authority
NL
Netherlands
Application number
NL7406748A
Other versions
NL172956C (nl
NL172956B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7406748A publication Critical patent/NL7406748A/xx
Publication of NL172956B publication Critical patent/NL172956B/nl
Application granted granted Critical
Publication of NL172956C publication Critical patent/NL172956C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7406748,A 1973-05-21 1974-05-20 Werkwijze voor het bereiden van 25-hydroxycholesterol en zijn 3-esters. NL172956C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00362569A US3822254A (en) 1973-05-21 1973-05-21 Synthesis of 25-hydroxycholesterol

Publications (3)

Publication Number Publication Date
NL7406748A true NL7406748A (nl) 1974-11-25
NL172956B NL172956B (nl) 1983-06-16
NL172956C NL172956C (nl) 1983-11-16

Family

ID=23426617

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7406748,A NL172956C (nl) 1973-05-21 1974-05-20 Werkwijze voor het bereiden van 25-hydroxycholesterol en zijn 3-esters.

Country Status (9)

Country Link
US (1) US3822254A (nl)
JP (1) JPS5614679B2 (nl)
AT (1) AT343294B (nl)
BE (1) BE815252A (nl)
CH (1) CH617442A5 (nl)
DE (1) DE2424498C3 (nl)
FR (1) FR2236854B1 (nl)
GB (2) GB1445237A (nl)
NL (1) NL172956C (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5218700B2 (nl) * 1973-02-16 1977-05-24
US3928397A (en) * 1973-03-02 1975-12-23 Eisai Co Ltd New 5-cholestene derivatives and preparation thereof
US3959320A (en) * 1974-09-23 1976-05-25 The Upjohn Company Process and compounds
US3976636A (en) * 1974-10-10 1976-08-24 The Upjohn Company Process and compounds
US3994934A (en) * 1975-01-27 1976-11-30 The Upjohn Company Process for preparing Δ22 -25-oxy substituted sterol derivatives
US4264512A (en) * 1975-09-29 1981-04-28 The Regents Of The University Of California 3-Deoxy-1α-hydroxy- and 3-deoxy-1α,25-dihydroxycholecalciferol and processes for the preparation thereof
US3994878A (en) * 1975-10-10 1976-11-30 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol and alkanoyl derivatives thereof
CH628907A5 (en) * 1975-10-10 1982-03-31 Hoffmann La Roche Process for the preparation of 24,25-dihydroxycholesterol derivatives
US4038272A (en) * 1975-10-20 1977-07-26 Hoffmann-La Roche Inc. Stereospecific syntheses of 24r,25- and 24s,25-dihydroxycholesterol and alkanoyl derivatives thereof
JPS5371056A (en) * 1976-12-08 1978-06-24 Chugai Pharmaceut Co Ltd Steroid derivs.
JPS53144563A (en) * 1977-05-19 1978-12-15 Chugai Pharmaceut Co Ltd Preparation of steroid derivatives
EP0015122B1 (en) * 1979-02-15 1983-09-14 Teijin Limited New 25-hydroxy-24-oxocholestane derivatives and preparation thereof
CH644873A5 (de) * 1980-02-12 1984-08-31 Hoffmann La Roche Verfahren zur herstellung von cholesterinderivaten.
WO2006047022A1 (en) 2004-10-25 2006-05-04 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
US8399441B2 (en) 2004-10-25 2013-03-19 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
US9034859B2 (en) 2011-04-06 2015-05-19 Virginia Commonwealth University Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
EP3086793B1 (en) 2013-12-24 2022-05-11 Virginia Commonwealth University Use of oxygenated cholesterol sulfates (ocs) for the treatment of kidney dysfunction
AU2017305239C1 (en) 2016-08-02 2022-08-18 Durect Corporation Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
CN111320663B (zh) * 2018-12-13 2023-01-24 上海医药工业研究院 一种24-胆烯烯酸乙酯中间体的制备方法
WO2021005618A1 (en) * 2019-07-09 2021-01-14 Fermenta Biotech Limited Synthesis of cholesterol and vitamin d3 from phytosterols
CN111138512A (zh) * 2019-12-27 2020-05-12 郑州手性药物研究院有限公司 一种合成25-羟基胆固醇中间体的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2012069B1 (nl) * 1968-07-01 1973-06-08 Wisconsin Alumni Res Found
US3846455A (en) * 1972-05-22 1974-11-05 Eisai Co Ltd Process for the preparation of 25-hydroxy-cholesterol and esters thereof

Also Published As

Publication number Publication date
JPS5018458A (nl) 1975-02-26
BE815252A (fr) 1974-11-20
AT343294B (de) 1978-05-26
ATA416374A (de) 1977-09-15
JPS5614679B2 (nl) 1981-04-06
CH617442A5 (nl) 1980-05-30
FR2236854A1 (nl) 1975-02-07
DE2424498A1 (de) 1974-12-12
DE2424498C3 (de) 1981-04-02
DE2424498B2 (de) 1980-06-04
GB1445237A (en) 1976-08-04
GB1445236A (en) 1976-08-04
FR2236854B1 (nl) 1977-10-21
US3822254A (en) 1974-07-02
NL172956C (nl) 1983-11-16
NL172956B (nl) 1983-06-16

Similar Documents

Publication Publication Date Title
AR201235Q (nl)
AR201231Q (nl)
FR2236854B1 (nl)
AR201229Q (nl)
AR199451A1 (nl)
AU477823B2 (nl)
AR195948A1 (nl)
AU476873B1 (nl)
AU477824B2 (nl)
AR200885A1 (nl)
AR200256A1 (nl)
AR197627A1 (nl)
AR196382A1 (nl)
AR195311A1 (nl)
AR201432A1 (nl)
AR193950A1 (nl)
AR196212Q (nl)
AR196123Q (nl)
CH564204A5 (nl)
AU479522A (nl)
CH564429A5 (nl)
AU479405A (nl)
CH561597A5 (nl)
CH559482A5 (nl)
CH181474A4 (nl)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee